English

FUTUREBIOTICS INC

EDGAR

Quarterly report (10-Q) · filed 2000-10-13

19 filing records in this dataset, filed from 1996-07-11 to 2000-10-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.83 million USD

2000-08-31 · USD

Exact inputs and evidence

Revenue: 4833000 USD Source

Operating margin

-9.89%

2000-08-31 · %

Exact inputs and evidence

Operating Income: -478000 USD Source
Revenue: 4833000 USD Source

Operating cash flow

78 thousand USD

2000-08-31 · USD

Exact inputs and evidence

Operating Cash Flow: 246000 USD Source
Operating Cash Flow: 168000 USD Source

Free cash flow

78 thousand USD

2000-08-31 · USD

Exact inputs and evidence

Operating Cash Flow: 246000 USD Source
Operating Cash Flow: 168000 USD Source
Capital Expenditure: 68000 USD Source
Capital Expenditure: 68000 USD Source

Cash and cash equivalents: 72 thousand USD 2000-08-31 Source
Exact value

72000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-1.12 million USD

1999-09-01 – 2000-08-31

Exact inputs and evidence

Net income: -1685000 USD · 1998-12-01 – 1999-11-30 Source
Net income: -655000 USD · 1998-12-01 – 1999-08-31 Source
Net income: 85000 USD · 1999-12-01 – 2000-02-29 Source
Net income: -69000 USD · 2000-03-01 – 2000-05-31 Source
Net income: -107000 USD · 2000-06-01 – 2000-08-31 Source

Operating cash flow

1.77 million USD

1999-09-01 – 2000-08-31

Exact inputs and evidence

Operating cash flow: 1382000 USD · 1998-12-01 – 1999-11-30 Source
Operating cash flow: -144000 USD · 1998-12-01 – 1999-08-31 Source
Operating cash flow: 188000 USD · 1999-12-01 – 2000-02-29 Source
Operating cash flow: 168000 USD · 1999-12-01 – 2000-05-31 Source
Operating cash flow: 188000 USD · 1999-12-01 – 2000-02-29 Source
Operating cash flow: 246000 USD · 1999-12-01 – 2000-08-31 Source
Operating cash flow: 168000 USD · 1999-12-01 – 2000-05-31 Source

Capital expenditure

68 thousand USD

1999-09-01 – 2000-08-31

Exact inputs and evidence

Capital expenditure: 0 USD · 1998-12-01 – 1999-11-30 Source
Capital expenditure: 0 USD · 1998-12-01 – 1999-08-31 Source
Capital expenditure: 29000 USD · 1999-12-01 – 2000-02-29 Source
Capital expenditure: 68000 USD · 1999-12-01 – 2000-05-31 Source
Capital expenditure: 29000 USD · 1999-12-01 – 2000-02-29 Source
Capital expenditure: 68000 USD · 1999-12-01 – 2000-08-31 Source
Capital expenditure: 68000 USD · 1999-12-01 – 2000-05-31 Source

Free cash flow

1.7 million USD

1999-09-01 – 2000-08-31

Exact inputs and evidence

Operating cash flow: 1382000 USD · 1998-12-01 – 1999-11-30 Source
Operating cash flow: -144000 USD · 1998-12-01 – 1999-08-31 Source
Operating cash flow: 188000 USD · 1999-12-01 – 2000-02-29 Source
Operating cash flow: 168000 USD · 1999-12-01 – 2000-05-31 Source
Operating cash flow: 188000 USD · 1999-12-01 – 2000-02-29 Source
Operating cash flow: 246000 USD · 1999-12-01 – 2000-08-31 Source
Operating cash flow: 168000 USD · 1999-12-01 – 2000-05-31 Source
Capital expenditure: 0 USD · 1998-12-01 – 1999-11-30 Source
Capital expenditure: 0 USD · 1998-12-01 – 1999-08-31 Source
Capital expenditure: 29000 USD · 1999-12-01 – 2000-02-29 Source
Capital expenditure: 68000 USD · 1999-12-01 – 2000-05-31 Source
Capital expenditure: 29000 USD · 1999-12-01 – 2000-02-29 Source
Capital expenditure: 68000 USD · 1999-12-01 – 2000-08-31 Source
Capital expenditure: 68000 USD · 1999-12-01 – 2000-05-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-10-13.

Financial data available through: 1999-11-30.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 1999-11-30
Operating income: 5 of 11 periods available· newest 1999-11-30
Net income: 5 of 11 periods available· newest 1999-11-30
Operating cash flow: 5 of 11 periods available· newest 1999-11-30
Capital expenditure: 5 of 11 periods available· newest 1999-11-30
Total assets: 5 of 11 periods available· newest 1999-11-30
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 1999-11-30
Current liabilities: 4 of 11 periods available· newest 1999-11-30
Cash and cash equivalents: 5 of 11 periods available· newest 1999-11-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-29.1%

Prior period

USD 10.3 million

1997-12-01 – 1998-11-30
Current period

USD 7.31 million

1998-12-01 – 1999-11-30

Exact inputs and evidence

7305000 − 10304000 = -2999000 USD

10304000 USD · 1997-12-01 – 1998-11-30
Inspect prior input Prior source
7305000 USD · 1998-12-01 – 1999-11-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Year-over-year change in Revenue: -2999000 USD Concept: fundies:Revenue Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7305000 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1181 Input fundies:Revenue: 10304000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1181
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 705,000

Prior period

−USD 980,000

1997-12-01 – 1998-11-30
Current period

−USD 1.69 million

1998-12-01 – 1999-11-30

Exact inputs and evidence

-1685000 − -980000 = -705000 USD

-980000 USD · 1997-12-01 – 1998-11-30
Inspect prior input Prior source
-1685000 USD · 1998-12-01 – 1999-11-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Year-over-year change in Net income: -705000 USD Concept: fundies:NetIncome Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1685000 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1330 Input fundies:NetIncome: -980000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1330
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+5.3%

Prior period

USD 1.31 million

1997-12-01 – 1998-11-30
Current period

USD 1.38 million

1998-12-01 – 1999-11-30

Exact inputs and evidence

1382000 − 1313000 = 69000 USD

1313000 USD · 1997-12-01 – 1998-11-30
Inspect prior input Prior source
1382000 USD · 1998-12-01 – 1999-11-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Year-over-year change in Operating cash flow: 69000 USD Concept: fundies:OperatingCashFlow Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 1382000 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352 Input fundies:OperatingCashFlow: 1313000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 39,000

1997-12-01 – 1998-11-30
Current period

USD 0

1998-12-01 – 1999-11-30

Exact inputs and evidence

0 − 39000 = -39000 USD

39000 USD · 1997-12-01 – 1998-11-30
Inspect prior input Prior source
0 USD · 1998-12-01 – 1999-11-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Year-over-year change in Capital expenditure: -39000 USD Concept: fundies:CapitalExpenditure Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356 Input fundies:CapitalExpenditure: 39000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1998-12-01 – 1999-11-30

Revenue USD 7.31 million 100% of revenue
Operating costs Derived USD 8.79 million 120% of revenue
Operating income −USD 1.49 million −20% of revenue
Tax, interest and other Derived USD 199,000 2.7% of revenue
Net income −USD 1.69 million −23% of revenue

Cash

Operating cash flow USD 1.38 million 19% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived USD 1.38 million 19% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 95%
1996 Operating loss: operating costs were 103% of revenue.
1997 Operating loss: operating costs were 110% of revenue.
1998 Operating loss: operating costs were 109% of revenue.
1999 Operating loss: operating costs were 120% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1994-12-01 – 1995-11-30	10646911	10130656 Derived	516255	74533 Derived	441722	-2783163 Derived	Source 1994-12-01 – 1995-11-30: 10646911 USD Inspect Revenue Open source 1994-12-01 – 1995-11-30: 516255 USD Inspect Operating Income Open source 1994-12-01 – 1995-11-30: 441722 USD Inspect Net Income Open source 1994-12-01 – 1995-11-30: -2738440 USD Inspect Operating Cash Flow Open source 1994-12-01 – 1995-11-30: 44723 USD Inspect Capital Expenditure Open source
1996 1995-12-01 – 1996-11-30	12713000	13085000 Derived	-372000	-82000 Derived	-290000	-90000 Derived	Source 1995-12-01 – 1996-11-30: 12713000 USD Inspect Revenue Open source 1995-12-01 – 1996-11-30: -372000 USD Inspect Operating Income Open source 1995-12-01 – 1996-11-30: -290000 USD Inspect Net Income Open source 1995-12-01 – 1996-11-30: 107000 USD Inspect Operating Cash Flow Open source 1995-12-01 – 1996-11-30: 197000 USD Inspect Capital Expenditure Open source
1997 1996-12-01 – 1997-11-30	11682000	12888000 Derived	-1206000	-172000 Derived	-1034000	-709000 Derived	Source 1996-12-01 – 1997-11-30: 11682000 USD Inspect Revenue Open source 1996-12-01 – 1997-11-30: -1206000 USD Inspect Operating Income Open source 1996-12-01 – 1997-11-30: -1034000 USD Inspect Net Income Open source 1996-12-01 – 1997-11-30: -694000 USD Inspect Operating Cash Flow Open source 1996-12-01 – 1997-11-30: 15000 USD Inspect Capital Expenditure Open source
1998 1997-12-01 – 1998-11-30	10304000	11218000 Derived	-914000	66000 Derived	-980000	1274000 Derived	Source 1997-12-01 – 1998-11-30: 10304000 USD Inspect Revenue Open source 1997-12-01 – 1998-11-30: -914000 USD Inspect Operating Income Open source 1997-12-01 – 1998-11-30: -980000 USD Inspect Net Income Open source 1997-12-01 – 1998-11-30: 1313000 USD Inspect Operating Cash Flow Open source 1997-12-01 – 1998-11-30: 39000 USD Inspect Capital Expenditure Open source
1999 1998-12-01 – 1999-11-30	7305000	8791000 Derived	-1486000	199000 Derived	-1685000	1382000 Derived	Source 1998-12-01 – 1999-11-30: 7305000 USD Inspect Revenue Open source 1998-12-01 – 1999-11-30: -1486000 USD Inspect Operating Income Open source 1998-12-01 – 1999-11-30: -1685000 USD Inspect Net Income Open source 1998-12-01 – 1999-11-30: 1382000 USD Inspect Operating Cash Flow Open source 1998-12-01 – 1999-11-30: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.3M 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-11-30	Revenue	10646911	Revenue: 10646911 Open source
19961996-11-30	Revenue	12713000	Revenue: 12713000 Open source
19971997-11-30	Revenue	11682000	Revenue: 11682000 Open source
19981998-11-30	Revenue	10304000	Revenue: 10304000 Open source
19991999-11-30	Revenue	7305000	Revenue: 7305000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-29.1% 1999

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-11-30	Year over year	No prior comparable period	Revenue: 10646911 Open source
19961996-11-30	Year over year	19.4%	Revenue: 12713000 Open source Revenue: 10646911 Open source
19971997-11-30	Year over year	-8.1%	Revenue: 11682000 Open source Revenue: 12713000 Open source
19981998-11-30	Year over year	-11.8%	Revenue: 10304000 Open source Revenue: 11682000 Open source
19991999-11-30	Year over year	-29.1%	Revenue: 7305000 Open source Revenue: 10304000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -20.3% 1999

Net margin -23.1% 1999

Free cash flow margin 18.9% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-11-30	Operating margin	4.8%	Operating Income: 516255 Open source Revenue: 10646911 Open source
19961996-11-30	Operating margin	-2.9%	Operating Income: -372000 Open source Revenue: 12713000 Open source
19971997-11-30	Operating margin	-10.3%	Operating Income: -1206000 Open source Revenue: 11682000 Open source
19981998-11-30	Operating margin	-8.9%	Operating Income: -914000 Open source Revenue: 10304000 Open source
19991999-11-30	Operating margin	-20.3%	Operating Income: -1486000 Open source Revenue: 7305000 Open source
19951995-11-30	Net margin	4.1%	Net Income: 441722 Open source Revenue: 10646911 Open source
19961996-11-30	Net margin	-2.3%	Net Income: -290000 Open source Revenue: 12713000 Open source
19971997-11-30	Net margin	-8.9%	Net Income: -1034000 Open source Revenue: 11682000 Open source
19981998-11-30	Net margin	-9.5%	Net Income: -980000 Open source Revenue: 10304000 Open source
19991999-11-30	Net margin	-23.1%	Net Income: -1685000 Open source Revenue: 7305000 Open source
19951995-11-30	Free cash flow margin	-26.1%	Revenue: 10646911 Open source Operating Cash Flow: -2738440 Open source Capital Expenditure: 44723 Open source
19961996-11-30	Free cash flow margin	-0.7%	Revenue: 12713000 Open source Operating Cash Flow: 107000 Open source Capital Expenditure: 197000 Open source
19971997-11-30	Free cash flow margin	-6.1%	Revenue: 11682000 Open source Operating Cash Flow: -694000 Open source Capital Expenditure: 15000 Open source
19981998-11-30	Free cash flow margin	12.4%	Revenue: 10304000 Open source Operating Cash Flow: 1313000 Open source Capital Expenditure: 39000 Open source
19991999-11-30	Free cash flow margin	18.9%	Revenue: 7305000 Open source Operating Cash Flow: 1382000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.4M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-11-30	Operating cash flow	-2738440	Operating Cash Flow: -2738440 Open source
19961996-11-30	Operating cash flow	107000	Operating Cash Flow: 107000 Open source
19971997-11-30	Operating cash flow	-694000	Operating Cash Flow: -694000 Open source
19981998-11-30	Operating cash flow	1313000	Operating Cash Flow: 1313000 Open source
19991999-11-30	Operating cash flow	1382000	Operating Cash Flow: 1382000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 1.4M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-11-30	Free cash flow	-2783163	Operating Cash Flow: -2738440 Open source Capital Expenditure: 44723 Open source
19961996-11-30	Free cash flow	-90000	Operating Cash Flow: 107000 Open source Capital Expenditure: 197000 Open source
19971997-11-30	Free cash flow	-709000	Operating Cash Flow: -694000 Open source Capital Expenditure: 15000 Open source
19981998-11-30	Free cash flow	1274000	Operating Cash Flow: 1313000 Open source Capital Expenditure: 39000 Open source
19991999-11-30	Free cash flow	1382000	Operating Cash Flow: 1382000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-11-30	Liabilities / assets	Not reported	Total Assets: 10142000 Open source
1996-11-30	Liabilities / assets	Not reported	Total Assets: 11764000 Open source
1997-11-30	Liabilities / assets	Not reported	Total Assets: 10975000 Open source
1998-11-30	Liabilities / assets	Not reported	Total Assets: 7340000 Open source
1999-11-30	Liabilities / assets	Not reported	Total Assets: 4431000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

54.65× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1995-11-30	Current assets / current liabilities	Not reported	No source recorded
19961996-11-30	Current assets / current liabilities	96.5×	Current Assets: 8209927 Open source Current Liabilities: 85078 Open source
19971997-11-30	Current assets / current liabilities	74.44×	Current Assets: 9454000 Open source Current Liabilities: 127000 Open source
19981998-11-30	Current assets / current liabilities	97.58×	Current Assets: 7026000 Open source Current Liabilities: 72000 Open source
19991999-11-30	Current assets / current liabilities	54.65×	Current Assets: 3880000 Open source Current Liabilities: 71000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1994-12-01 – 1995-11-30	USD 441,722 Exact value Exact value: 441722 USD 1994-12-01 – 1995-11-30: 441722 USD Inspect Net Income Open source Share or cite Citation for Net Income · FUTUREBIOTICS INC · 1995-11-30 FUTUREBIOTICS INC (edgar:922200) Net Income: 441722 USD Concept: fundies:NetIncome Period: 1994-12-01 to 1995-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ANetIncome&period=1995-11-30&surface=latest&period_type=duration&start=1994-12-01&unit=USD&dimensions= Input fundies:NetIncome: 441722 USD (1994-12-01 to 1995-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-98-000598.txt#1433 The citation records this snapshot. The page link may show a newer release later.	−USD 2.74 million Exact value Exact value: -2738440 USD 1994-12-01 – 1995-11-30: -2738440 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FUTUREBIOTICS INC · 1995-11-30 FUTUREBIOTICS INC (edgar:922200) Operating Cash Flow: -2738440 USD Concept: fundies:OperatingCashFlow Period: 1994-12-01 to 1995-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3AOperatingCashFlow&period=1995-11-30&surface=latest&period_type=duration&start=1994-12-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2738440 USD (1994-12-01 to 1995-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-98-000598.txt#1579 The citation records this snapshot. The page link may show a newer release later.	USD 44,723 Exact value Exact value: 44723 USD 1994-12-01 – 1995-11-30: 44723 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FUTUREBIOTICS INC · 1995-11-30 FUTUREBIOTICS INC (edgar:922200) Capital Expenditure: 44723 USD Concept: fundies:CapitalExpenditure Period: 1994-12-01 to 1995-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ACapitalExpenditure&period=1995-11-30&surface=latest&period_type=duration&start=1994-12-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44723 USD (1994-12-01 to 1995-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-98-000598.txt#1583 The citation records this snapshot. The page link may show a newer release later.	−USD 2.78 million Calculation and evidence -2738440 − 44723 USD Exact free cash flow: -2783163 USD 1994-12-01 – 1995-11-30: -2738440 USD · Inspect Operating Cash Flow · Source 1994-12-01 – 1995-11-30: 44723 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FUTUREBIOTICS INC · 1995-11-30 FUTUREBIOTICS INC (edgar:922200) Free cash flow: -2783163 USD Concept: free-cash-flow Period: 1994-12-01 to 1995-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2738440 USD (1994-12-01 to 1995-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-98-000598.txt#1579 Input fundies:CapitalExpenditure: 44723 USD (1994-12-01 to 1995-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-98-000598.txt#1583 The citation records this snapshot. The page link may show a newer release later.
1996 1995-12-01 – 1996-11-30	−USD 290,000 Exact value Exact value: -290000 USD 1995-12-01 – 1996-11-30: -290000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FUTUREBIOTICS INC · 1996-11-30 FUTUREBIOTICS INC (edgar:922200) Net Income: -290000 USD Concept: fundies:NetIncome Period: 1995-12-01 to 1996-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ANetIncome&period=1996-11-30&surface=latest&period_type=duration&start=1995-12-01&unit=USD&dimensions= Input fundies:NetIncome: -290000 USD (1995-12-01 to 1996-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-99-000832.txt#1520 The citation records this snapshot. The page link may show a newer release later.	USD 107,000 Exact value Exact value: 107000 USD 1995-12-01 – 1996-11-30: 107000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FUTUREBIOTICS INC · 1996-11-30 FUTUREBIOTICS INC (edgar:922200) Operating Cash Flow: 107000 USD Concept: fundies:OperatingCashFlow Period: 1995-12-01 to 1996-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3AOperatingCashFlow&period=1996-11-30&surface=latest&period_type=duration&start=1995-12-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 107000 USD (1995-12-01 to 1996-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-99-000832.txt#1542 The citation records this snapshot. The page link may show a newer release later.	USD 197,000 Exact value Exact value: 197000 USD 1995-12-01 – 1996-11-30: 197000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FUTUREBIOTICS INC · 1996-11-30 FUTUREBIOTICS INC (edgar:922200) Capital Expenditure: 197000 USD Concept: fundies:CapitalExpenditure Period: 1995-12-01 to 1996-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ACapitalExpenditure&period=1996-11-30&surface=latest&period_type=duration&start=1995-12-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 197000 USD (1995-12-01 to 1996-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-99-000832.txt#1546 The citation records this snapshot. The page link may show a newer release later.	−USD 90,000 Calculation and evidence 107000 − 197000 USD Exact free cash flow: -90000 USD 1995-12-01 – 1996-11-30: 107000 USD · Inspect Operating Cash Flow · Source 1995-12-01 – 1996-11-30: 197000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FUTUREBIOTICS INC · 1996-11-30 FUTUREBIOTICS INC (edgar:922200) Free cash flow: -90000 USD Concept: free-cash-flow Period: 1995-12-01 to 1996-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 107000 USD (1995-12-01 to 1996-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-99-000832.txt#1542 Input fundies:CapitalExpenditure: 197000 USD (1995-12-01 to 1996-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-99-000832.txt#1546 The citation records this snapshot. The page link may show a newer release later.
1997 1996-12-01 – 1997-11-30	−USD 1.03 million Exact value Exact value: -1034000 USD 1996-12-01 – 1997-11-30: -1034000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FUTUREBIOTICS INC · 1997-11-30 FUTUREBIOTICS INC (edgar:922200) Net Income: -1034000 USD Concept: fundies:NetIncome Period: 1996-12-01 to 1997-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ANetIncome&period=1997-11-30&surface=latest&period_type=duration&start=1996-12-01&unit=USD&dimensions= Input fundies:NetIncome: -1034000 USD (1996-12-01 to 1997-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1330 The citation records this snapshot. The page link may show a newer release later.	−USD 694,000 Exact value Exact value: -694000 USD 1996-12-01 – 1997-11-30: -694000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FUTUREBIOTICS INC · 1997-11-30 FUTUREBIOTICS INC (edgar:922200) Operating Cash Flow: -694000 USD Concept: fundies:OperatingCashFlow Period: 1996-12-01 to 1997-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3AOperatingCashFlow&period=1997-11-30&surface=latest&period_type=duration&start=1996-12-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -694000 USD (1996-12-01 to 1997-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352 The citation records this snapshot. The page link may show a newer release later.	USD 15,000 Exact value Exact value: 15000 USD 1996-12-01 – 1997-11-30: 15000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FUTUREBIOTICS INC · 1997-11-30 FUTUREBIOTICS INC (edgar:922200) Capital Expenditure: 15000 USD Concept: fundies:CapitalExpenditure Period: 1996-12-01 to 1997-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ACapitalExpenditure&period=1997-11-30&surface=latest&period_type=duration&start=1996-12-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15000 USD (1996-12-01 to 1997-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356 The citation records this snapshot. The page link may show a newer release later.	−USD 709,000 Calculation and evidence -694000 − 15000 USD Exact free cash flow: -709000 USD 1996-12-01 – 1997-11-30: -694000 USD · Inspect Operating Cash Flow · Source 1996-12-01 – 1997-11-30: 15000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FUTUREBIOTICS INC · 1997-11-30 FUTUREBIOTICS INC (edgar:922200) Free cash flow: -709000 USD Concept: free-cash-flow Period: 1996-12-01 to 1997-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -694000 USD (1996-12-01 to 1997-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352 Input fundies:CapitalExpenditure: 15000 USD (1996-12-01 to 1997-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356 The citation records this snapshot. The page link may show a newer release later.
1998 1997-12-01 – 1998-11-30	−USD 980,000 Exact value Exact value: -980000 USD 1997-12-01 – 1998-11-30: -980000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FUTUREBIOTICS INC · 1998-11-30 FUTUREBIOTICS INC (edgar:922200) Net Income: -980000 USD Concept: fundies:NetIncome Period: 1997-12-01 to 1998-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ANetIncome&period=1998-11-30&surface=latest&period_type=duration&start=1997-12-01&unit=USD&dimensions= Input fundies:NetIncome: -980000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1330 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Exact value Exact value: 1313000 USD 1997-12-01 – 1998-11-30: 1313000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FUTUREBIOTICS INC · 1998-11-30 FUTUREBIOTICS INC (edgar:922200) Operating Cash Flow: 1313000 USD Concept: fundies:OperatingCashFlow Period: 1997-12-01 to 1998-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3AOperatingCashFlow&period=1998-11-30&surface=latest&period_type=duration&start=1997-12-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1313000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352 The citation records this snapshot. The page link may show a newer release later.	USD 39,000 Exact value Exact value: 39000 USD 1997-12-01 – 1998-11-30: 39000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FUTUREBIOTICS INC · 1998-11-30 FUTUREBIOTICS INC (edgar:922200) Capital Expenditure: 39000 USD Concept: fundies:CapitalExpenditure Period: 1997-12-01 to 1998-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ACapitalExpenditure&period=1998-11-30&surface=latest&period_type=duration&start=1997-12-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356 The citation records this snapshot. The page link may show a newer release later.	USD 1.27 million Calculation and evidence 1313000 − 39000 USD Exact free cash flow: 1274000 USD 1997-12-01 – 1998-11-30: 1313000 USD · Inspect Operating Cash Flow · Source 1997-12-01 – 1998-11-30: 39000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FUTUREBIOTICS INC · 1998-11-30 FUTUREBIOTICS INC (edgar:922200) Free cash flow: 1274000 USD Concept: free-cash-flow Period: 1997-12-01 to 1998-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1313000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352 Input fundies:CapitalExpenditure: 39000 USD (1997-12-01 to 1998-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356 The citation records this snapshot. The page link may show a newer release later.
1999 1998-12-01 – 1999-11-30	−USD 1.69 million Exact value Exact value: -1685000 USD 1998-12-01 – 1999-11-30: -1685000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Net Income: -1685000 USD Concept: fundies:NetIncome Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ANetIncome&period=1999-11-30&surface=latest&period_type=duration&start=1998-12-01&unit=USD&dimensions= Input fundies:NetIncome: -1685000 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1330 The citation records this snapshot. The page link may show a newer release later.	USD 1.38 million Exact value Exact value: 1382000 USD 1998-12-01 – 1999-11-30: 1382000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Operating Cash Flow: 1382000 USD Concept: fundies:OperatingCashFlow Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3AOperatingCashFlow&period=1999-11-30&surface=latest&period_type=duration&start=1998-12-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1382000 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1998-12-01 – 1999-11-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200/explain?concept=fundies%3ACapitalExpenditure&period=1999-11-30&surface=latest&period_type=duration&start=1998-12-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356 The citation records this snapshot. The page link may show a newer release later.	USD 1.38 million Calculation and evidence 1382000 − 0 USD Exact free cash flow: 1382000 USD 1998-12-01 – 1999-11-30: 1382000 USD · Inspect Operating Cash Flow · Source 1998-12-01 – 1999-11-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FUTUREBIOTICS INC · 1999-11-30 FUTUREBIOTICS INC (edgar:922200) Free cash flow: 1382000 USD Concept: free-cash-flow Period: 1998-12-01 to 1999-11-30 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/922200?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1382000 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1352 Input fundies:CapitalExpenditure: 0 USD (1998-12-01 to 1999-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/922200/0000889812-00-001007.txt#1356 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

19 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0000922200, 922200, edgar:922200

FUTUREBIOTICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1998-12-01 – 1999-11-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation